Study Design
RECRUITMENT
This investigator-initiated, open-label RCT (Combined Drug Approach to Prevent Ischemia-Reperfusion Injury During Transplantation of Livers [CAPITL]) with 2 parallel arms was conducted between September 2013 and February 2018, with 1-year follow-up, at the University Hospitals Leuven, Belgium. Ethical approval was obtained from the Ethics Committee Research UZ / KU Leuven and the Federal Agency for Medicines and Health Products of Belgium. Before recruitment started, the trial was registered at ClinicalTrials.gov (